Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
Glenda Gray(South African Medical Research Council), Lubbe Wiesner(Jisc), Maphoshane Nchabeleng(Sefako Makgatho Health Sciences University), Mookho Malahleha(University of Cape Town), Michele P. Andrasik(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nigel Garrett(Centre for the AIDS Programme of Research in South Africa), Nicole Grunenberg(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dishiki Kalonji(South African Medical Research Council), Graeme Meintjes, Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Zoe Moodie(Fred Hutch Cancer Center), Pearl Selepe(Aurum Institute), Tania Adonis(Aurum Institute), Thozama Dubula(Nelson Mandela Academic Hospital), Mpho Lerato Sikhosana(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mary Allen(National Institutes of Health), David Benkeser(Emory University), Cleon N. Ncayiya(Desmond Tutu HIV Foundation), Millicent Atujuna(Desmond Tutu HIV Foundation), Pamela Mda(Nelson Mandela Academic Hospital), Vimla Naicker(South African Medical Research Council), Adrian Puren(National Institute for Communicable Diseases), Craig Innes(Aurum Institute), Tricia Philip(University of the Witwatersrand), Nishanta Singh(South African Medical Research Council), Zakir Gaffoor(South African Medical Research Council), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Simbarashe Takuva(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carter Bentley(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nivashnee Naicker(Centre for the AIDS Programme of Research in South Africa), Fatima Laher(Norwegian Womens Public Health Association), Bontle Modibedi(University of the Witwatersrand), Philip Kotze(Jisc), William Brumskine(Aurum Institute), Brittany Prigmore(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Girisha Kistnasami(South African Medical Research Council), Nima S. Hejazi(Jisc), Erica Lazarus(Norwegian Womens Public Health Association), Gladys Kobane(Aurum Institute), Philisiwe B. Makhoba(Jisc), Jia Jin Kee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Amy Ward(Wellcome Centre for Infectious Diseases Research in Africa), Megan Jones(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Katlego Mapetla(University of Cape Town), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Matsontso Mathebula(Sefako Makgatho Health Sciences University), Sheetal Kassim(Desmond Tutu HIV Foundation), Shelly Ramirez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Doug Grove(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Modulakgotla Sebe(Aurum Institute)
Cited by 231
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
Assessing differential impacts of COVID-19 on black communities
|Annals of Epidemiology|2020|1.2k
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|699
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|622